Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F56AQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,188
Award facts
- Contract value 100% obligated
- $13,188.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Boostrix TDAP vaccine in 0.5mL syringes, with a ceiling value of $13,188.24. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award based on open competition. The contract is scheduled for ultimate completion on November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 comprehensive global pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates capability in delivering diverse pharmaceutical products including medications, vaccines, and specialized medical supplies across multiple therapeutic domains. As a DLA Troop Support prime vendor, AmerisourceBergen serves customers including the Defense Health Agency and U.S. Coast Guard, positioning this TDAP vaccine delivery order as part of the company's ongoing support for military medical supply chains and immunization requirements.
Quick answers
Who was awarded contract SPE2DR26F56AQ?
SPE2DR26F56AQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F56AQ worth?
The government has obligated $13,188 on SPE2DR26F56AQ.
Is contract SPE2DR26F56AQ an order under another contract?
Yes. SPE2DR26F56AQ is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F56AQ competed?
The extent of competition for SPE2DR26F56AQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award